OTCMWSNAF
Market cap206kUSD
Dec 23, Last price
0.01USD
1D
132.56%
1Q
17.65%
IPO
-99.55%
Name
Wesana Health Holdings Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-2m
L-79.59%
CFO
-865k
L-88.74%
Profile
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is based in Chicago, Illinois.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2021‑04 | 2020‑04 | 2019‑04 | 2018‑04 | 2017‑04 | 2016‑04 | 2015‑04 | |
| Income | ||||||||||
Revenues | 267 | |||||||||
Cost of revenue | 3,064 | 13,813 | ||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (3,064) | (13,546) | ||||||||
NOPBT Margin | ||||||||||
Operating Taxes | (310) | 5,433 | 30 | |||||||
Tax Rate | ||||||||||
NOPAT | 310 | (8,497) | (13,576) | |||||||
Net income | (1,755) -79.59% | (8,599) 9,763.70% | (34,339) 33,721.65% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 849 | 11,970 | ||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | 249 | 295 | 203 | |||||||
Long-term debt | 930 | |||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 153 | |||||||||
Net debt | (22) | (155) | (5,454) | |||||||
| Cash flow | ||||||||||
Cash from operating activities | (865) | (7,688) | (11,991) | |||||||
CAPEX | (20) | |||||||||
Cash from investing activities | 504 | 512 | 2,422 | |||||||
Cash from financing activities | (64) | 1,147 | 14,922 | |||||||
FCF | 1,514 | (9,370) | (14,092) | |||||||
| Balance | ||||||||||
Cash | 270 | 451 | 6,587 | |||||||
Long term investments | 1 | |||||||||
Excess cash | 271 | 451 | 6,573 | |||||||
Stockholders' equity | (271) | (5,425) | 2,604 | |||||||
Invested Capital | 247 | 6,685 | 5,909 | |||||||
ROIC | 8.94% | |||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | 35,039 | 34,380 | 23,153 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | (3,064) | (13,492) | ||||||||
EV/EBITDA | ||||||||||
Interest | 75 | 30 | ||||||||
Interest/NOPBT | ||||||||||